Myriad Genetics, Inc. (MYGN) SWOT Profile

Find Industry reports, Company profiles
ReportLinker and Market Statistics

>> Get this Report Now by email!

Myriad Genetics, Inc. (MYGN) SWOT Profile
Published on April 2010

Report Summary


Summary

GlobalData's Myriad Genetics, Inc. (MYGN) SWOT Profile is a comprehensive business, functional and strategic analysis of Myriad
Genetics, Inc.. The profile delves into the operations of the company to present an in-depth analysis of the various aspects related to
its business. It analyzes the company's business structure, operations, major products and services, prospects, locations and
subsidiaries, executive biographies and key competitors. The hallmark of the profile is the detailed strategic analysis of the company.
This highlights and presents an unbiased view of its key strengths and weaknesses and the potential opportunities and threats. The
profile helps you formulate strategies that augment your business by understanding your partners, customers and competitors better.

Myriad Genetics, Inc. (Myriad) is a research focused biotechnology company engaged in the development and commercialization of
small molecular diagnostic products. The company offers different medicine products to improve patient's health such as predictive
medicine, prognostic medicine and personalized medicine products in the areas of oncology and CNS related disorders. In January
2009, the company acquired all rights of bevirimat from Panacos Pharmaceuticals, Inc.

Key Recent Developments

Apr 19, 2010: Myriad Study Shows PTEN Gene Is Useful In Predicting Prostate Cancer Recurrence
Mar 02, 2010: Myriad Genetics Unveils Prolaris To Predict Prostate Cancer Recurrence
Feb 25, 2010: Patients Of Community Oncology Practices At Risk For Hereditary Breast/Ovarian Cancer: Myriad Genetics

Scope

- Examines key information about company for business intelligence.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented objectively.
Business, strategic and operational aspects are taken into account.
- Opportunities available to the company are sized up and its growth potential assessed. Competitive and/or technological threats are
highlighted.
- The profile contains valuable and critical company information ' business structure and operations, the company history, major
products and services, prospects, key competitors, key employees, executive biographies, important locations and subsidiaries.
- The profile provides detailed financial ratios for the past five years as well as interim ratios for the last five interim periods for major
public companies.
- Financial ratios presented for major public companies include revenue trends, profitability, growth, margins and returns, liquidity and
leverage, financial position and efficiency ratios.

Note: Some of the elements mentioned above will be included in the profile based on the availability of information.

Myriad Genetics, Inc. (MYGN) SWOT Profile Page 1/6


Reasons to Buy

- A quick 'one-stop-shop' to understand the company clearly.
- Get detailed and exhaustive information and operational & strategic analysis on companies operating in your industry.
- Enhance business/sales activities by understanding customers' businesses better.
- Identify prospective partners and suppliers ' with key data on their businesses and locations.
- Understand and respond to your competitors' business structure, strategies, and explore weaknesses.
- With key historical ratios, compare your company's financial trends with those of your competitors.
- Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Table of Content

Table of Contents
Table of Contents 2
List of Tables 3

List of Figures 3
Myriad Genetics, Inc. - Key Facts 4
Myriad Genetics, Inc. - Business Description 4
Myriad Genetics, Inc. - Major Products and Services 6
Myriad Genetics, Inc. - History 7
Myriad Genetics, Inc. - SWOT Analysis 12
SWOT Analysis - Overview 12
Myriad Genetics, Inc. - Strengths 12
Strength - Rising Profitability Levels 12
Strength - Increasing Molecular Diagnostic Product Sales 12
Myriad Genetics, Inc. - Weaknesses 12
Weakness - Pending Litigation 12
Weakness - Single Laboratory Facility 12
Myriad Genetics, Inc. - Opportunities 13
Opportunity - Emerging Markets 13
Opportunity - Growing Incidence of Cancer 13
Opportunity - Spin-off of Myriad Genetics 13
Opportunity - Strategic Acquisitions 13
Myriad Genetics, Inc. - Threats 13
Threat - Uncertain R&D Outcomes 14
Threat - Tightening of the FDA's Regulatory Oversight 14
Threat - Competitive Pressures 14
Myriad Genetics, Inc. - Key Competitors 15
Myriad Genetics, Inc. - Key Employees 16
Myriad Genetics, Inc. - Key Employee Biographies 17
Myriad Genetics, Inc. - Company Statement 19
Myriad Genetics, Inc. - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Myriad Genetics, Inc. - Financial Ratios 22



Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 22
Financial Ratios - Interim Ratios 23
Financial Ratios - Ratio Charts 24
Recent Developments 25
Mar 02, 2010: Myriad Genetics Unveils Prolaris To Predict Prostate Cancer Recurrence 25
Feb 25, 2010: Patients Of Community Oncology Practices At Risk For Hereditary Breast/Ovarian Cancer: Myriad Genetics 25
Jan 26, 2010: Myriad Updates On Patients Receiving Dosing Regimens Of FOLFOX6, FOLFOX6 Plus Avastin 26
Jan 06, 2010: Myriad Genetics Collaborates With Mammography Reporting Systems 27
Nov 03, 2009: Myriad Genetics Q1 Fiscal 2010 Net Income Increases 27
Aug 25, 2009: Myriad Genetics Q4 Fiscal 2009 Net Income Decreases 28
Aug 25, 2009: Myriad Genetics' Revenue Up By 47% For FY09 28
Jul 02, 2009: Myriad Genetics Spins Off Research, Pharmaceutical Business 29
Jun 30, 2009: Myriad Genetics Posts Preliminary Results For Q4,09 29
May 04, 2009: Myriad Genetics Reports Profit Of $25.3 Million For Q3 Fiscal 2009 29
Appendix 31
Methodology 31
Ratio Definitions 31
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Myriad Genetics, Inc., Key Information 1
Myriad Genetics, Inc., Key Ratios 1
Myriad Genetics, Inc., Share Data 1
Myriad Genetics, Inc., SWOT Analysis 1
Myriad Genetics, Inc., Key Facts 4
Myriad Genetics, Inc., Major Products and Services 6
Myriad Genetics, Inc., History 7
Myriad Genetics, Inc., Key Employees 16
Myriad Genetics, Inc., Key Employee Biographies 17
Myriad Genetics, Inc., Subsidiaries 21
Myriad Genetics, Inc., Ratios based on current share price 22
Myriad Genetics, Inc., Annual Ratios 22
Myriad Genetics, Inc., Interim Ratios 23
Currency Codes 31
Capital Market Ratios 31
Equity Ratios 32
Profitability Ratios 33
Cost Ratios 33
Liquidity Ratios 34
Leverage Ratios 34
Efficiency Ratios 35

List of Figures
Myriad Genetics, Inc., Performance Chart (2005 - 2009) 1
Myriad Genetics, Inc., Ratio Charts 24

Companies Mentioned



The following companies are the major competitors of Myriad Genetics, Inc.:
Orchid Cellmark
Applied Biosystems Group
Exact Sciences Corporation
Human Genome Sciences, Inc.
Vernalis plc
Incyte Corporation
Cytogen Corporation
Amgen Inc.
Affymetrix, Inc.



Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 150.00 Quantity: _____

Site License--USD 300.00 Quantity: _____

Corporate License--USD 450.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________



Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Myriad Genetics, Inc. (MYGN) SWOT Profile

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Andere mochten auch

Andere mochten auch (16)

Mehr von ReportLinker.com

Mehr von ReportLinker.com (20)

Myriad Genetics, Inc. (MYGN) SWOT Profile